tiprankstipranks
Trending News
More News >
Curative Biosciences Inc (CBDX)
OTHER OTC:CBDX
US Market

Curative Biosciences (CBDX) Financial Statements

Compare
6 Followers

Curative Biosciences Financial Overview

Curative Biosciences's market cap is currently $51.58K. The company's EPS TTM is $; its P/E ratio is ―; Curative Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 17
Income Statement
Total Revenue$ 0.00
Gross Profit$ -2.85K
Operating Income$ -53.20K
EBITDA$ -50.35K
Net Income$ -53.20K
Balance Sheet
Cash & Short-Term Investments$ 0.00
Total Assets$ 2.27K
Total Debt$ 62.83K
Net Debt$ 62.83K
Total Liabilities$ 633.07K
Stockholders' Equity$ -630.80K
Cash Flow
Free Cash Flow$ -12.80K
Operating Cash Flow$ -12.80K
Investing Cash Flow$ 0.00
Financing Cash Flow$ 12.80K
Currency in USD

Curative Biosciences Earnings and Revenue History

Curative Biosciences Debt to Assets

Curative Biosciences Cash Flow

Curative Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.